Brain fog after COVID: can two common drugs clear it?

NCT ID NCT07722000

Completed Symptom relief Sponsor: Beni-Suef University Source: ClinicalTrials.gov ↗

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial investigates whether ginkgo biloba, piracetam, or a combination of both can help people recover from persistent symptoms after COVID-19, such as memory problems and fatigue. The study enrolls adults aged 18 to 70 who had COVID-19 within the past three months. Participants receive one of the treatments, and researchers track changes in cognitive function and fatigue levels over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ginkgo biloba and/or piracetam
What this could lead to: If effective, these treatments could offer a simple, widely available option for managing post-COVID cognitive and fatigue symptoms.
What could go wrong: This is a small, early-stage trial with no placebo group, so results may be inconclusive. Ginkgo biloba and piracetam are generally safe but can cause side effects like headache or dizziness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 long COVID-19 post-COVID-19 disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 GINKGO BILOBA PIRACETAM POST COVID-19 SYNDROME

Contacts and locations

Show contact details

Locations

Beni Suef University

Banī Suwayf, Beni Suweif Governorate, 62511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.